Jacobs Levy Equity Management
IMA

Jacobs Levy Equity Management’s ImageneBio Inc IMA Stock Holding History

Jacobs Levy Equity Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Buy
26,663
+7,936
+42% +$51.5K ﹤0.01% 936
2025
Q4 		$129K Buy
18,727
+1,019
+6% +$7.56K ﹤0.01% 902
2025
Q3 		$144K Buy
17,708
+1,199
+7% +$15.9K ﹤0.01% 931
2025
Q2 		$265K Sell
16,509
-3,948
-19% -$58K ﹤0.01% 954
2025
Q1 		$314K Sell
20,457
-6,827
-25% -$118K ﹤0.01% 972
2024
Q4 		$537K Sell
27,284
-5,112
-16% -$103K ﹤0.01% 806
2024
Q3 		$673K Sell
32,396
-2,969
-8% -$60K ﹤0.01% 796
2024
Q2 		$700K Sell
35,365
-7,422
-17% -$131K ﹤0.01% 800
2024
Q1 		$729K Buy
42,787
+38,104
+814% +$694K ﹤0.01% 766
2023
Q4 		$111K Sell
4,683
-88
-2% -$2.87K ﹤0.01% 950
2023
Q3 		$248K Buy
4,771
+2,453
+106% +$148K ﹤0.01% 898
2023
Q2 		$182K Buy
2,318
+806
+53% +$57.8K ﹤0.01% 932
2023
Q1 		$62.6K Buy
+1,512
New +$69.5K ﹤0.01% 939
2022
Q3 		– Sell
-3,410
Closed -$181K – 1087
2022
Q2 		$181K Buy
+3,410
New +$188K ﹤0.01% 962

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management's IMA Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its ImageneBio Inc (IMA) stake by 42% in Q1 2026, buying an estimated $51.5K and bringing the position to 26,663 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Jacobs Levy Equity Management first reported a position in IMA in Q2 2022 and has held it in 14 quarters since. The position peaked at $729K in Q1 2024. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Jacobs Levy Equity Management held 26,663 shares of ImageneBio Inc worth $133K as of Q1 2026.
  • Jacobs Levy Equity Management bought 7,936 ImageneBio Inc shares in Q1 2026, an estimated $51.5K.
  • ImageneBio Inc made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #936 holding.
  • Jacobs Levy Equity Management first reported a position in ImageneBio Inc in Q2 2022 and has held it in 14 quarters since.
  • Jacobs Levy Equity Management's ImageneBio Inc position peaked at $729K in Q1 2024.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.